Dr. Reddy's Laboratories Limited - Product Pipeline Review - 2015
Global Markets Direct’s, ‘Dr. Reddy's Laboratories Limited - Product Pipeline Review - 2015’, provides an overview of the Dr. Reddy's Laboratories Limited’s pharmaceutical research and development focus.
This report provides comprehensive information on the current therapeutic developmental pipeline of Dr. Reddy's Laboratories Limited’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.
Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.
Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
- The report provides brief overview of Dr. Reddy's Laboratories Limited including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of Dr. Reddy's Laboratories Limited’s human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the Dr. Reddy's Laboratories Limited’s pipeline products
Reasons to buy
- Evaluate Dr. Reddy's Laboratories Limited’s strategic position with total access to detailed information on its product pipeline - Assess the growth potential of Dr. Reddy's Laboratories Limited in its therapy areas of focus - Identify new drug targets and therapeutic classes in the Dr. Reddy's Laboratories Limited’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of Dr. Reddy's Laboratories Limited and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of Dr. Reddy's Laboratories Limited - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Explore the dormant and discontinued projects of Dr. Reddy's Laboratories Limited and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues
Our reports have been used by over 10K customers, including:
463 pages •
By Global Industry Analysts
• Jan 2019
This report analyzes the worldwide markets for Biotechnology Instrumentation in US$ Thousand by the following Product Segments: DNA Sequencing Systems, DNA Synthesizers, Electrophoresis Systems, Immunoassay Systems, Laboratory Automation, Liquid Chromatography Systems, Mass Spectrometry, MicroArrays, and Protein/Peptide Synthesizers. The...
2018 Coagulation POC and Laboratory Instrumentation, and Strategic Profiles of Leading Suppliers This 71-page report reviews current instrumentation technologies, and compares features of leading automated and semiautomated analyzers.
Asia-Pacific cancer screening market Asia-Pacific is a rapidly growing cancer market. The market is forecasted to grow at a compound annual growth rate (CAGR) of 17.3% resulting in annual revenue of USD 32.26 Bn during the forecast period (2018-2023). Asia Pacific is rapidly adopting the latest technological developments and is contributing...
In the report the esoteric testing market, the market is expected to reach US$ $ 45,081.6 Mn in 2025 from US$ 19,868.2 in 2017. The market is estimated to grow with a CAGR of 11.7% from 2018-2025. The esoteric testing market is driven by the driving factor such as rising prevalence of infectious diseases, growing awareness regarding early...
This report provides a worldwide overview of the cancer diagnostics market, including mortality statistics and scientific views on the etiology of major types of cancer, estimates of the number of laboratories performing cancer tests, as well as ten-year test volume and sales forecasts by country.Contains 11 pages and 3 tables
This report provides a worldwide overview of the infectious disease testing market environment, structure, size and growth. Includes estimates of the number of laboratories performing infectious disease tests, as well as ten-year test volume and sales forecasts by country.Contains 15 pages and 3 tables
This report provides estimates of the number of laboratories performing tumor marker assays, as well as test volume and sales forecasts by country.The report also presents strategic analyses of leading current and emerging suppliers of cancer diagnostic products in terms of their sales, market shares, product portfolios, distribution...
KEY FINDINGS The global laboratory filtration market is expected to grow with a CAGR of 6.87% during the forecasted period 2019-2027. Laboratory filtration helps in removal of pollutants such as fine sediment particulates and phosphorus & nitrogen particulate species. These media filters are also used for industrial, commercial...
This report provides a worldwide overview of the molecular diagnostics market, including estimates of facilities performing DNA sequencing and molecular diagnostic testing, as well as 5-year test volume and sales forecasts by country.Contains 15 pages and 4 tables
250 pages •
By Global Industry Analysts
• Jan 2019
This report analyzes the worldwide markets for Dental Laboratories in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2016 through 2024. Also, a five-year historic...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.